Prevalence and Dynamics of BCR-ABL Independent Gene Mutations in Chronic Phase CML Patients

被引：0
|
作者：
Ruppert, Lioba [1 ]
Rinke, Jenny [1 ]
Waldau, Anja [1 ]
Pfirrmann, Markus [2 ]
Hochhaus, Andreas [1 ]
Ernst, Thomas [1 ]
机构：
[1] Univ Klinikum Jena, Klin Innere Med 2, Onkol Forschungslab, Jena, Germany
[2] Ludwig Maximilians Univ Munchen, Inst Med Informat Verarbeitung Biometrie & Epidem, Munich, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
486
引用
收藏
页码：106 / 106
页数：1
相关论文
共 50 条
  • [21] Leukemic stem cells of chronic phase CML patients possess uniquely elevated BCR-ABL kinase activity and acquire spontaneous BCR-ABL kinase domain mutations at a high frequency.
    Jiang, XY
    Saw, KM
    Eaves, A
    Eaves, C
    BLOOD, 2005, 106 (11) : 132A - 132A
  • [22] Presence of novel compound BCR-ABL mutations in late chronic and advanced phase imatinib sensitive CML patients indicates their possible role in CML progression
    Akram, Afia Muhammad
    Iqbal, Zafar
    Akhtar, Tanveer
    Khalid, Ahmed Mukhtar
    Sabar, Muhammad Farooq
    Qazi, Mahmood Hussain
    Aziz, Zeba
    Sajid, Nadia
    Aleem, Aamer
    Rasool, Mahmood
    Asif, Muhammad
    Aloraibi, Saleh
    Aljamaan, Khaled
    Iqbal, Mudassar
    CANCER BIOLOGY & THERAPY, 2017, 18 (04) : 214 - 221
  • [23] BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients
    M Marega
    R G Piazza
    A Pirola
    S Redaelli
    A Mogavero
    I Iacobucci
    I Meneghetti
    M Parma
    E M Pogliani
    C Gambacorti-Passerini
    Leukemia, 2010, 24 : 1445 - 1449
  • [24] BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients
    Marega, M.
    Piazza, R. G.
    Pirola, A.
    Redaelli, S.
    Mogavero, A.
    Iacobucci, I.
    Meneghetti, I.
    Parma, M.
    Pogliani, E. M.
    Gambacorti-Passerini, C.
    LEUKEMIA, 2010, 24 (08) : 1445 - 1449
  • [25] UNDETECTABLE BCR-ABL REARRANGEMENTS IN SOME CML PATIENTS ARE DUE TO A DELETION MUTATION IN THE BCR GENE
    HIROSAWA, S
    AOKI, N
    MATSUSHIME, H
    SHIBUYA, M
    AMERICAN JOURNAL OF HEMATOLOGY, 1988, 28 (01) : 33 - 36
  • [26] BCR-ABL independent gene mutations contributing to treatment resistance in chronic myeloid leukemia: A pilot study
    Khaled, N.
    Mossner, M.
    Fabarius, A.
    Nowak, D.
    Rinaldetti, S.
    Spiess, B.
    Seifarth, W.
    Meggendorfer, M.
    Hofmann, W. -K.
    Saussele, S.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 147 - 147
  • [27] Characterization of the BCR-ABL kinase domain mutations in CML patients failing imanitib therapy
    Kuo, F. C.
    Kuo, C.
    Sholl, L.
    Longtine, J. A.
    LABORATORY INVESTIGATION, 2007, 87 : 249A - 249A
  • [28] Detection of BCR-ABL kinase domain mutations in patients with CML and Ph plus ALL
    Zhang, T
    Nwachukwu, B
    Kamel-Raid, S
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2004, 6 (04): : 416 - 416
  • [29] BCR-ABL targeted therapy in chronic myeloid leukemia (CML).
    Goldman, JM
    Deininger, M
    Melo, JV
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 515 - 515
  • [30] BCR-ABL peptide immunisation in chronic myeloid leukaemia (CML)
    Clark, RE
    Knight, K
    Wang, L
    Rojas, JM
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (07) : 54 - 54
12345